Stocks
Sino Biopharmaceutical Limited (SBMFF) EBITDA margin US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | 74.0% | 25.7% | 26.6% | 21.2% | 25.1% | 20.9% | ||
| Changes by years, y/y, % | +44pp | -48pp | +1pp | -5pp | +4pp | -3.2% | |||
Sino Biopharmaceutical Limited. EBITDA margin, %
Sino Biopharmaceutical Limited. EBITDA margin, changes, pp
Sino Biopharmaceutical Limited (SBMFF) EBITDA margin US GAAP (quarter values) |
||||||||
| 2024Q2 | 2024Q3 | 2024Q4 | 2025Q1 | 2025Q2 | LTM ? | |||
| EBITDA margin, % | ? | 24.9% | 16.8% | 16.7% | 22.4% | 22.4% | 20.9% | |
| Changes by years, y/y, % | +1pp | -2pp | -2pp | |||||
| Changes by quarters, q/q, % | 0pp | -8pp | 0pp | +6pp | 0pp | |||
